Skip to main content
. Author manuscript; available in PMC: 2013 Nov 22.
Published in final edited form as: JAMA Pediatr. 2013 Jan;167(1):10.1001/jamapediatrics.2013.419. doi: 10.1001/jamapediatrics.2013.419

Figure 1.

Figure 1

Screening effectiveness for diabetes (percentage of cases identified) plotted against screening efficiency (costs per case identified) from a societal perspective. A, Base-case analysis; B, alternative estimates of hemoglobin Alc (HbAlc) test performance. OGTT indicates oral glucose tolerance test.

HHS Vulnerability Disclosure